Alder Biopharmaceuticals Inc (ALDR) Stock Price & Overview
NASDAQ:ALDR
Current stock price
The current stock price of ALDR is 18.88 null. Today ALDR is down by -0.21%. In the past month the price increased by 1.34%. In the past year, price increased by 43.36%.
ALDR Key Statistics
- Market Cap
- 1.583B
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -4.45
- Dividend Yield
- N/A
ALDR Stock Performance
ALDR Stock Chart
ALDR Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to ALDR. When comparing the yearly performance of all stocks, ALDR is one of the better performing stocks in the market, outperforming 98.26% of all stocks.
ALDR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALDR. ALDR has a bad profitability rating. Also its financial health evaluation is rather negative.
ALDR Earnings
ALDR Forecast & Estimates
ALDR Financial Highlights
Over the last trailing twelve months ALDR reported a non-GAAP Earnings per Share(EPS) of -4.449999999999999. The EPS increased by 0.89% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -68.61% | ||
| ROE | N/A | ||
| Debt/Equity | 0.89 |
ALDR Ownership
About ALDR
Company Profile
Alder Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and seeks to commercialize therapeutic antibodies. It is developing monoclonal antibodies comprising ALD403, for the prevention of migraine; and Clazakizumab, in the treatment of rheumatoid arthritis and psoriatic arthritis. Alder Biopharmaceuticals Inc. is headquartered in Bothell, Washington.
Company Info
Alder Biopharmaceuticals Inc
11804 NORTH CREEK PARKWAY SOUTH
BOTHELL WA 98011
CEO: Robert W. Azelby
Phone: 425-205-2900
Alder Biopharmaceuticals Inc / ALDR FAQ
Can you describe the business of Alder Biopharmaceuticals Inc?
Alder Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and seeks to commercialize therapeutic antibodies. It is developing monoclonal antibodies comprising ALD403, for the prevention of migraine; and Clazakizumab, in the treatment of rheumatoid arthritis and psoriatic arthritis. Alder Biopharmaceuticals Inc. is headquartered in Bothell, Washington.
What is the current price of ALDR stock?
The current stock price of ALDR is 18.88 null. The price decreased by -0.21% in the last trading session.
Does ALDR stock pay dividends?
ALDR does not pay a dividend.
What is the ChartMill rating of Alder Biopharmaceuticals Inc stock?
ALDR has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the PE ratio for ALDR stock?
Alder Biopharmaceuticals Inc (ALDR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.45).
What is Alder Biopharmaceuticals Inc worth?
Alder Biopharmaceuticals Inc (ALDR) has a market capitalization of 1.58B null. This makes ALDR a Small Cap stock.